Skip to main content
Premium Trial:

Request an Annual Quote

Bruker, Affymetrix Shares Drop Sharply

Shares in Bruker BioSciences and Affymetrix each dropped more than 17 percent this past week after both firms released their first-quarter results.
 
Affymetrix failed to meet Wall Street expectations for profit and revenue, leading to a 17.4 percent decline for the five-day trading period ended Tuesday. Meanwhile, Bruker shares fell 17.8 percent, even though it posted first-quarter revenue growth of 16.5 percent. Bruker’s stock had surged throughout the first quarter, and while a sell-off is not uncommon following the release of quarterly results, the reasons for such a massive decline are not clear.
 
On the other end of the spectrum, shares in Sequenom gained 19 percent for the week after the firm announced it had placed $20 million of common stock with institutional investors.
 
Overall, the BCW Index dipped .2 percent, while the Dow Jones Industrial Average gained 1.4 percent, the Nasdaq was up .3 percent, and the Nasdaq Biotech Index was flat with last week.

 
 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Closing Price
(May 1, 2007)
Starting Price
(
April 24, 2007)
% change
Affymetrix
AFFX
25.9
31.34
-17.36
Agilent
A
35.99
35.34
1.84
Applied Biosystems
ABI
31.11
30.8
1.01
Beckman
BEC
63.32
62.06
2.03
Becton Dickinson
BDX
79.63
78.11
1.95
Bio-Rad
BIO
70.66
69.57
1.57
Bruker
BRKR
9.17
11.15
-17.76
Caliper
CALP
5.47
5.72
-4.37
Cepheid
CPHD
11.34
12.1
-6.28
Illumina
ILMN
32.69
32.77
-0.24
Invitrogen
IVGN
65.87
66.81
-1.41
Luminex
LMNX
13.75
14.21
-3.24
MDS
MDZ
19.25
18.88
1.96
Millipore
MIL
73.88
74.31
-0.58
PerkinElmer
PKI
24.31
24.79
-1.94
Qiagen
QGEN
17.68
17.69
-0.06
Sequenom
SQNM
3.56
2.99
19.06
Sigma-Aldrich
SIAL
42.29
41.51
1.88
Stratagene
STGN
10.78
10.73
0.47
Thermo
TMO
52.34
49.88
4.93
Third Wave
TWTI
5.32
5.74
-7.32
Waters
WAT
59.41
58.96
0.76
BCW Index Average  
34.26
34.34
-0.23
The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.